By Counterforce Health Team in Elfabrio (pegunigalsidase alfa-iwxj) —

Do You Qualify for Elfabrio Coverage by UnitedHealthcare in Michigan? Decision Tree & Next Steps

Quick Answer: Your Path to Elfabrio Coverage

If you have confirmed Fabry disease and UnitedHealthcare in Michigan: You'll need prior authorization through OptumRx. Start with genetic testing confirmation (GLA mutation) and enzyme levels. Most patients must try Galafold or Fabrazyme first due to step therapy. If denied, Michigan gives you 127 days to file external review with DIFS. First step today: Contact your doctor to request prior authorization submission via UnitedHealthcare's provider portal.

Table of Contents

  1. How to Use This Guide
  2. Eligibility Triage: Do You Qualify?
  3. If Likely Eligible: Your Action Plan
  4. If Possibly Eligible: Tests You Need
  5. If Not Yet Eligible: Alternative Options
  6. If Denied: Michigan Appeals Process
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & Solutions
  9. Frequently Asked Questions

How to Use This Guide

This decision tree helps you determine your likelihood of getting Elfabrio (pegunigalsidase alfa) covered by UnitedHealthcare in Michigan. Work through each section in order—don't skip the eligibility triage, as it'll save you time and frustration.

What you'll need handy:

  • Your UnitedHealthcare member ID card
  • Recent lab results and genetic testing
  • List of previous Fabry disease treatments
  • Contact info for your prescribing physician
Note: This is educational information, not medical advice. Always consult your healthcare provider for treatment decisions.

Eligibility Triage: Do You Qualify?

Answer these questions to determine your coverage likelihood:

1. Diagnosis Confirmation

Do you have confirmed Fabry disease with:

  • Pathogenic GLA gene mutation (genetic testing), AND
  • For males: Alpha-galactosidase A enzyme deficiency (<5% normal activity)
  • For females: Genetic testing showing pathogenic variant (enzyme levels unreliable)

✅ Yes = Continue to question 2
❌ No = Go to Possibly Eligible section

2. Age and Severity

Are you:

  • 18 years or older (Elfabrio is FDA-approved for adults only), AND
  • Experiencing symptoms requiring enzyme replacement therapy (kidney, heart, or neurologic involvement)

✅ Yes = Continue to question 3
❌ No = Go to Not Yet Eligible section

3. Prior Therapy Requirements

Have you tried and failed/cannot tolerate:

  • Migalastat (Galafold) if your mutation is amenable, OR
  • Agalsidase beta (Fabrazyme) or agalsidase alfa (Replagal)

✅ Yes = Go to Likely Eligible section
❌ No = Go to Possibly Eligible section

If Likely Eligible: Your Action Plan

You meet the basic criteria for Elfabrio coverage. Here's your step-by-step path:

Document Checklist

Gather these before your doctor submits the prior authorization:

Required Clinical Documentation:

  • Genetic testing report showing pathogenic GLA mutation
  • Alpha-galactosidase A enzyme levels (if male)
  • Recent clinical notes (within 6 months) documenting:
    • Current symptoms and organ involvement
    • Previous treatment failures/intolerances
    • Baseline kidney function (eGFR)
    • Cardiac assessment if applicable

Prior Therapy Documentation:

  • Records showing trial and failure of step therapy requirements
  • Documented reasons for discontinuation (lack of efficacy, adverse reactions, contraindications)

Submission Process

Step 1: Your doctor submits prior authorization through:

  • UnitedHealthcare Provider Portal (fastest method)
  • Phone: 866-889-8054
  • Fax: (verify current number via provider portal)

Step 2: Include these key elements in the request:

  • ICD-10 code: E75.21 (Fabry disease)
  • Requested dosing: 1 mg/kg IV every 2 weeks
  • Site of care: Infusion center or physician office
  • Medical necessity letter citing FDA labeling and clinical guidelines

Step 3: Track your request:

  • Standard review: 15 business days
  • Urgent review: 72 hours (requires physician attestation of urgency)
Tip: Submit 30 days before current therapy runs out to avoid treatment gaps.

If Possibly Eligible: Tests You Need

You may qualify but need additional testing or documentation:

Missing Diagnosis Confirmation

For males: Start with alpha-galactosidase A enzyme assay

  • Test: Blood or serum α-Gal A activity
  • Normal range: >5% of mean normal activity
  • If low/absent: Proceed to genetic testing for confirmation

For females: Go directly to genetic testing

  • Test: GLA gene sequencing (blood, saliva, or buccal swab)
  • Enzyme levels are unreliable in women due to X-linked inheritance

Genetic Testing Options:

Timeline to Reapply

  • Genetic testing results: 2-4 weeks
  • Enzyme assay results: 1-2 weeks
  • Resubmit PA once results confirm diagnosis

If Not Yet Eligible: Alternative Options

If you don't meet standard criteria, consider these pathways:

Alternative Therapies to Discuss

  1. Migalastat (Galafold) - Oral therapy for amenable mutations
  2. Agalsidase beta (Fabrazyme) - Standard enzyme replacement therapy
  3. Clinical trials - Check ClinicalTrials.gov for Fabry disease studies

Exception Request Strategy

Work with your doctor to request coverage exceptions based on:

  • Unique clinical circumstances
  • Contraindications to standard therapies
  • Prior treatment failures with detailed documentation

When patients face coverage challenges for specialized treatments like Elfabrio, Counterforce Health helps transform insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to create point-by-point rebuttals aligned with each insurer's specific requirements, significantly improving approval rates for complex rare disease therapies.

If Denied: Michigan Appeals Process

UnitedHealthcare denied your Elfabrio request? Here's your appeal roadmap:

Internal Appeals (First Step)

Timeline: 180 days from denial date to file How to file:

  • Online: UnitedHealthcare member portal
  • Phone: Member services number on your ID card
  • Mail: Address provided in denial letter

Required documents:

  • Copy of denial letter
  • Medical records supporting necessity
  • Physician letter explaining why Elfabrio is medically necessary

Michigan External Review (Final Step)

When to use: After completing internal appeals Timeline: 127 days from final denial to file with DIFS How to file:

Decision timeframes:

  • Standard review: 60 days maximum
  • Expedited review: 72 hours (requires physician letter stating delay would harm patient)

Required form: Request for External Review (FIS 0018)

Important: Michigan's external review decisions are binding on UnitedHealthcare. If approved, they must cover the treatment.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required before coverage UnitedHealthcare Provider Portal
Step Therapy Try Galafold or Fabrazyme first UHC formulary guidelines
Age Restriction 18+ years (FDA approval) FDA Elfabrio label
Diagnosis Code E75.21 (Fabry disease) ICD-10 coding manual
Site of Care Infusion center/physician office Elfabrio prescribing information
Dosing 1 mg/kg IV every 2 weeks FDA-approved dosing

Common Denial Reasons & Solutions

Denial Reason How to Overturn
"Not medically necessary" Submit detailed medical necessity letter with FDA labeling citations and clinical evidence
"Step therapy not completed" Document trials/failures of Galafold and Fabrazyme with specific dates and reasons for discontinuation
"Off-label use" Emphasize FDA approval for adult Fabry disease (not off-label)
"Site of care restriction" Confirm infusion center administration per FDA requirements
"Experimental/investigational" Reference FDA approval date (May 2023) and established clinical evidence

Frequently Asked Questions

How long does UnitedHealthcare prior authorization take in Michigan? Standard review takes up to 15 business days. Urgent requests (with physician attestation) are decided within 72 hours.

What if Elfabrio is non-formulary on my plan? Non-formulary drugs can still be covered through prior authorization and medical exception processes. Work with your doctor to demonstrate medical necessity.

Can I request an expedited appeal in Michigan? Yes, if delay would seriously jeopardize your health. Your physician must provide a letter supporting the urgent need. DIFS decides expedited external reviews within 72 hours.

Does step therapy apply if I tried other treatments outside Michigan? Yes, prior treatment history from any location counts toward step therapy requirements. Ensure your doctor includes complete treatment records in the PA request.

What if I can't afford Elfabrio even with insurance? Contact Chiesi Total Care for patient assistance programs. They may offer copay support or free drug programs based on financial need.

How do I know if my GLA mutation is amenable to Galafold? Galafold's prescribing information lists amenable mutations. Your genetic counselor or physician can determine if your specific variant qualifies.

From Our Advocates: We've seen Michigan patients successfully appeal Elfabrio denials by emphasizing previous treatment failures and providing detailed documentation of disease progression. The key is working closely with your specialist to create a comprehensive medical necessity case that addresses UnitedHealthcare's specific step therapy requirements. While outcomes vary, thorough preparation significantly improves your chances.

When facing complex prior authorization requirements or denials, many patients and providers turn to specialized services like Counterforce Health, which helps create targeted appeals by analyzing insurance policies and crafting evidence-based responses that speak directly to each payer's criteria.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider regarding treatment decisions and insurance coverage options. Coverage policies may vary by specific UnitedHealthcare plan and can change over time. Verify current requirements with your insurer and healthcare team.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.